JAK inhibitor Rinvoq (upadacitinib) has been backed by the CHMP as a 15mg, once-daily treatment for adults with GCA, an ...

Late last week, you guys got the positive CHMP opinion, and Christel previously ... Is it, you know, visual acuity? Or Krish Krishnan, CEO, Cristal Biotech: No. We’re not we’re not looking ...

Late last week, you guys got the positive CHMP opinion, and Christel previously guided to a ... Ritu Baral, Analyst, TD Cowen: Yeah. Yes. Is it, you know, visual acuity? Or Krish Krishnan, CEO, ...

Ocular adverse reactions occurred in 77% of the 218 patients in the pooled safety population and included keratopathy (76%), changes in visual acuity ... opinion from the CHMP scientific committee ...

The CHMP has specifically backed Leqembi to treat mild cognitive impairment or mild dementia from Alzheimer’s but only for patients carrying one or no copy of the ApoE4 gene.

Eisai (ESAIY) and Biogen (BIIB) announced that the Committee for Medicinal Products for Human Use, CHMP, of the European Medicines Agency, EMA, has reaffirmed its positive opinion by consensus for ...

Krystal Biotech KRYS announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval of Vyjuvek ...

Novartis NVS announced that the Committee for Medicinal Products for Human Use (“CHMP”) of the European Medicines Agency has adopted a positive opinion for the label expansion of Fabhalta ...